国家医保局：支持中国药械“走出去”

Core Viewpoint - The National Medical Insurance Administration (NMIA) is actively promoting the "going global" strategy for Chinese medical devices and pharmaceuticals, focusing on building a supportive ecosystem through the collection and pricing platform for medical supplies [1][11]. Group 1: Event Overview - The NMIA held a seminar on January 17, 2026, in Beijing, attended by over 400 representatives from various sectors, including government, international organizations, financial institutions, and media [1]. - The discussion centered on enhancing the functionality of the medical supplies collection and pricing platform to support the international expansion of Chinese medical products [1]. Group 2: Policy and Financial Support - Representatives from relevant ministries introduced policies to support Chinese medical devices and pharmaceuticals, while financial institutions presented comprehensive financial service plans for these companies [1][5]. - The NMIA aims to leverage regional advantages of collection platforms to innovate international procurement models and enhance the internationalization of China's pharmaceutical industry [5]. Group 3: Market Expansion and Infrastructure - The NMIA is focusing on the differentiated development of collection platforms in regions like Guangxi, Xinjiang, Tianjin, and Ningbo, targeting Southeast Asia, Central Asia, and other Belt and Road countries [5]. - The establishment of a global pricing system for Chinese pharmaceuticals is a priority, with the goal of making China a leading source for innovative drugs globally [5][11]. Group 4: Ecosystem Development - The event aims to create a tightly integrated ecosystem combining government, industry, finance, and services to empower the internationalization of Chinese medical devices [11]. - The initiative seeks to share the achievements of China's pharmaceutical innovation with the world and contribute to global health [11].